- ITCI has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $7.9 million.
- ITCI has traded 6,935 shares today.
- ITCI is trading at a new lifetime high.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in ITCI with the Ticky from Trade-Ideas. See the FREE profile for ITCI NOW at Trade-Ideas More details on ITCI: Intra-Cellular Therapies, Inc., a biopharmaceutical company, discovers and develops small molecule drugs for the treatment of neuropsychiatric and neurologic disorders within the central nervous system (CNS). Currently there are 7 analysts that rate Intra-Cellular Therapies a buy, no analysts rate it a sell, and none rate it a hold. The average volume for Intra-Cellular Therapies has been 220,800 shares per day over the past 30 days. Intra-Cellular has a market cap of $951.8 million and is part of the health care sector and drugs industry. Shares are up 54.2% year-to-date as of the close of trading on Thursday. EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE. TheStreetRatings.com Analysis: